ロード中...
Pharmacokinetics and dynamics of famotidine in patients with renal failure.
1. Famotidine, a new histamine H2-receptor antagonist was administered intravenously (20 mg) to 22 patients with end stage renal disease during a dialysis free interval (n = 6) and during different blood purification processes including haemodialysis (HD; n = 4), intermittent haemofiltration (HF; n...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1988
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1386544/ https://ncbi.nlm.nih.gov/pubmed/2902874 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|